Fertility RiskCARENCT05509322
Care Expansion Across Remote Environments - Sub-Study of the SELF-GYN1 Trial
A study testing Subsidy for fertility consult and Invitation to purchase fertility consult in people with Fertility Risk, run by Turtle Health, Inc. at 1 site in United States.
Trial summary
This real-world, interventional sub-study will evaluate the impact of potential payer subsidies for Turtle Health at-home consults on subsequent interactions with the healthcare system within select sub-populations of interest. Read more about this study
- Who is it for?
- Ages 25 to 35 years, women only
- Conditions the study is for
- Fertility Risk
- What is being tested?
- Subsidy for fertility consult and Invitation to purchase fertility consult
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 0 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Jan 2023to 10 Apr 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 35 years
- Women only
- No healthy volunteers
- Adult
Who may be able to join
- All inclusion criteria from the SELF-GYN1 trial apply
- Participant in Mayo Clinic health system
- Lives in MN
- Belongs to a sub-population targeted for enrollment that has not yet met its enrollment target
- Consent to participate in electronic health record monitoring and outreach
Who cannot join
- All exclusion criteria from the SELF-GYN1 trial apply
- Planning to move away from MN in the next year
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Care Expansion Across Remote Environments - Substudy of the SELF-GYN [Sonograms Enable Looking Forward - Get Your iNformation] Extension - I Trial
This real-world, interventional sub-study will evaluate the impact of potential payer subsidies for Turtle Health at-home consults on subsequent interactions with the healthcare system within select sub-populations of interest.
Read the detailed description
The present study is a sub-study of the SELF-GYN1 study. The SELF-GYN1 study is a multicenter study designed to evaluate the efficacy and safety of the use of the Turtle Health Ultrasound Scanner for the acquisition of transvaginal ultrasound images by a study participant, with no previous training, in her home when guided by real-time remote supervision from a qualified and specially trained ultrasound technologist.
In addition to the main questions of the SELF-GYN1 study, additional questions related to patient decision-making and pricing dynamics for patients who purchase patient's decisions to purchase a fertility consult alongside enrolling in the SELF-GYN1 trial, will be studied at Mayo Clinic, through providing subsidies for the purchasing of the fertility consult.
- Conditions
- Fertility Risk
- Being tested
- Subsidy for fertility consult, Invitation to purchase fertility consult
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Subsidy for fertility consultOther
Some participants will receive a subsidy when they purchase the fertility consult.
Invitation to purchase fertility consultOther
Some participants will receive an invitation from their health center to purchase an at-home fertility consult.
| Study group | Role | What they receive |
|---|---|---|
| Invitation to fertility consult with subsidy | Experimental | This group will be invited to purchase a fertility consult, and will be offered a subsidy if they choose to purchase the consult. Receives: Other: Subsidy for fertility consult; Other: Invitation to purchase fertility consult |
| Invitation to fertility consult without subsidy | Active comparator | This group will be invited to purchase a fertility consult at full price. Receives: Other: Invitation to purchase fertility consult |
| Control (no invitation) | No intervention | This group will not receive invitations to purchase a fertility consult. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Image quality
Percent of women whose stills are clinical quality, in each of 3 populations of interest.
Measured: 6 weeks
Secondary outcomes (22)
False positives
Rate of false positives of 'significant findings'
Measured: 6 weeks
Recalled Net Promoter Score
Difference between recalled in-clinic Net Promoter Score and at-home Net Promoter Score. The Net Promoter Score has a range of 0-10 with higher scores indicating more favorable responses.
Measured: 6 weeks
Number of patients opening box at correct time
Confirming patient opens box at correct time (not early)
Measured: 6 weeks
Number of correct patients identified
Correct patient is identified by tech and tests (not wrong patient)
Measured: 6 weeks
Number of patients who used probe cover
Patient correctly applies probe cover without either a) failing to apply it or b) ripping it, including in low light or other sub-optimal conditions
Measured: 6 weeks
Number of patients placing probe in correct cavity
Patient places probe in correct cavity (vaginal vs. anal)
Measured: 6 weeks
Rate of return packages sent
Patient ships product back in a timely fashion
Measured: 6 weeks
Rate of probes that crack
Probe does not crack on out-return trip
Measured: 6 weeks
Rate of working probes
Probe remains in working condition
Measured: 6 weeks
Rate of probes being reprocessed
Probe is reprocessed properly per internal SOPs
Measured: 6 weeks
Adverse events
Number and type of adverse events that occur
Measured: 6 weeks
Number of participants per subsidy
Level of participation (purchase and completion of consult) per subsidy level within each cohort of interest
Measured: 6 months
Number of couples who participate
Level of participation in couple consults where offered - i.e., purchase of both male and female consult, per subsidy level within each cohort of interest
Measured: 6 months
Clinically significant findings
Percentage of patients in which clinically significant findings are identified
Measured: 6 weeks
Number of IVF cycles
Number of IVF cycles conducted
Measured: 6 months
Percentage of IVF cycles
Percentage of IVF cycles considered clinically necessary based on treating physician survey
Measured: 6 months
Number of gynecological surgeries
Number of gynecological surgeries conducted
Measured: 6 months
Percentage of minimally invasive gynecological surgeries
Percentage of those surgeries that are considered minimally invasive based on treating physician survey
Measured: 6 months
Percentage of gynecological surgeries
Percentage of those surgeries that are considered clinically necessary within next 12 months based on treating physician survey
Measured: 12 months
Number of additional TVUS
Number of additional transvaginal ultrasounds conducted to monitor findings identified during at-home consult
Measured: 6 months
Number of other follow-up care
Number of other follow-up care sought based on findings identified during at-home consult
Measured: 6 months
Percentage of follow up care per arm
Percentage of patients in each arm seeking follow up care of any kind; fertility care in particular after consult
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Aug 2022
- Study start1 Jan 2023 (estimated)
- Primary completion10 Apr 2023
- Study completion10 Apr 2023
Why it stopped: Study is no longer going to be occurring- no subjects were enrolled at any point.
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Fertility RiskStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Prospective, interventional, multi-arm real-world study
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- Turtle Health, Inc.
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05509322
- Sponsor's protocol ID
- 016a
- Acronym
- CARE
- Status last verified
- Apr 2023
- First submitted
- 10 Aug 2022
- Last updated
- 12 Apr 2023
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
Publications
Chung EH, Petishnok LC, Conyers JM, Schimer DA, Vitek WS, Harris AL, Brown MA, Jolin JA, Karmon A, Styer AK. Virtual Compared With In-Clinic Transvaginal Ultrasonography for Ovarian Reserve Assessment. Obstet Gynecol. 2022 Apr 1;139(4):561-570. doi: 10.1097/AOG.0000000000004698. Epub 2022 Mar 10.
PubMed 35271530Birch Petersen K, Maltesen T, Forman JL, Sylvest R, Pinborg A, Larsen EC, Macklon KT, Nielsen HS, Hvidman HW, Nyboe Andersen A. The Fertility Assessment and Counseling Clinic - does the concept work? A prospective 2-year follow-up study of 519 women. Acta Obstet Gynecol Scand. 2017 Mar;96(3):313-325. doi: 10.1111/aogs.13081. Epub 2017 Feb 3.
PubMed 27990627Farquhar C, Ekeroma A, Furness S, Arroll B. A systematic review of transvaginal ultrasonography, sonohysterography and hysteroscopy for the investigation of abnormal uterine bleeding in premenopausal women. Acta Obstet Gynecol Scand. 2003 Jun;82(6):493-504. doi: 10.1034/j.1600-0412.2003.00191.x.
PubMed 12780419
Study at a glance
From the registry record, last updated by the sponsor on 12 Apr 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Care Expansion Across Remote Environments - Substudy of the SELF-GYN [Sonograms Enable Looking Forward - Get Your iNformation] Extension - I Trial
- ClinicalTrials.gov ID
- NCT05509322
- Acronym / sponsor ID
- CARE / 016a
- Conditions
- Fertility Risk
- Study type
- Interventional
- Recruitment status
- WithdrawnReason stopped: Study is no longer going to be occurring- no subjects were enrolled at any point.
- Enrolment
- 0 participants (actual)
- Lead sponsor
- Turtle Health, Inc.Industry (pharma, biotech, devices)
- Study start
- 1 Jan 2023 (estimated)
- Primary completion
- 10 Apr 2023 (actual)
- Study completion
- 10 Apr 2023 (actual)
- First posted
- 22 Aug 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This real-world, interventional sub-study will evaluate the impact of potential payer subsidies for Turtle Health at-home consults on subsequent interactions with the healthcare system within select sub-populations of interest.
Detailed description
The present study is a sub-study of the SELF-GYN1 study. The SELF-GYN1 study is a multicenter study designed to evaluate the efficacy and safety of the use of the Turtle Health Ultrasound Scanner for the acquisition of transvaginal ultrasound images by a study participant, with no previous training, in her home when guided by real-time remote supervision from a qualified and specially trained ultrasound technologist.
In addition to the main questions of the SELF-GYN1 study, additional questions related to patient decision-making and pricing dynamics for patients who purchase patient's decisions to purchase a fertility consult alongside enrolling in the SELF-GYN1 trial, will be studied at Mayo Clinic, through providing subsidies for the purchasing of the fertility consult.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 3
- Model description
- Prospective, interventional, multi-arm real-world study
| Arm | Type | Receives |
|---|---|---|
| Invitation to fertility consult with subsidy | Experimental | Other: Subsidy for fertility consult, Other: Invitation to purchase fertility consultThis group will be invited to purchase a fertility consult, and will be offered a subsidy if they choose to purchase the consult. |
| Invitation to fertility consult without subsidy | Active comparator | Other: Invitation to purchase fertility consultThis group will be invited to purchase a fertility consult at full price. |
| Control (no invitation) | No intervention | –This group will not receive invitations to purchase a fertility consult. |
Who may qualify
- Ages
- 25 to 35 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- All inclusion criteria from the SELF-GYN1 trial apply
- Participant in Mayo Clinic health system
- Lives in MN
- Belongs to a sub-population targeted for enrollment that has not yet met its enrollment target
- Consent to participate in electronic health record monitoring and outreach
Key exclusion criteria (2 listed)
- All exclusion criteria from the SELF-GYN1 trial apply
- Planning to move away from MN in the next year
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Subsidy for fertility consultSome participants will receive a subsidy when they purchase the fertility consult. | Other | Invitation to fertility consult with subsidy |
| Invitation to purchase fertility consultSome participants will receive an invitation from their health center to purchase an at-home fertility consult. | Other | Invitation to fertility consult with subsidy, Invitation to fertility consult without subsidy |
Primary outcome
Image quality
Time frame: 6 weeks
Percent of women whose stills are clinical quality, in each of 3 populations of interest.
22 secondary outcomes
False positives
Time frame: 6 weeks
Recalled Net Promoter Score
Time frame: 6 weeks
Number of patients opening box at correct time
Time frame: 6 weeks
Number of correct patients identified
Time frame: 6 weeks
Number of patients who used probe cover
Time frame: 6 weeks
Number of patients placing probe in correct cavity
Time frame: 6 weeks
Rate of return packages sent
Time frame: 6 weeks
Rate of probes that crack
Time frame: 6 weeks
Rate of working probes
Time frame: 6 weeks
Rate of probes being reprocessed
Time frame: 6 weeks
Adverse events
Time frame: 6 weeks
Number of participants per subsidy
Time frame: 6 months
Number of couples who participate
Time frame: 6 months
Clinically significant findings
Time frame: 6 weeks
Number of IVF cycles
Time frame: 6 months
Percentage of IVF cycles
Time frame: 6 months
Number of gynecological surgeries
Time frame: 6 months
Percentage of minimally invasive gynecological surgeries
Time frame: 6 months
Percentage of gynecological surgeries
Time frame: 12 months
Number of additional TVUS
Time frame: 6 months
Number of other follow-up care
Time frame: 6 months
Percentage of follow up care per arm
Time frame: 6 months
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Apr 2023.
- Background: PubMed 35271530Chung EH, Petishnok LC, Conyers JM, Schimer DA, Vitek WS, Harris AL, Brown MA, Jolin JA, Karmon A, Styer AK. Virtual Compared With In-Clinic Transvaginal Ultrasonography for Ovarian Reserve Assessment. Obstet Gynecol. 2022 Apr 1;139(4):561-570. doi: 10.1097/AOG.0000000000004698. Epub 2022 Mar 10.
- Background: PubMed 27990627Birch Petersen K, Maltesen T, Forman JL, Sylvest R, Pinborg A, Larsen EC, Macklon KT, Nielsen HS, Hvidman HW, Nyboe Andersen A. The Fertility Assessment and Counseling Clinic - does the concept work? A prospective 2-year follow-up study of 519 women. Acta Obstet Gynecol Scand. 2017 Mar;96(3):313-325. doi: 10.1111/aogs.13081. Epub 2017 Feb 3.
- Background: PubMed 12780419Farquhar C, Ekeroma A, Furness S, Arroll B. A systematic review of transvaginal ultrasonography, sonohysterography and hysteroscopy for the investigation of abnormal uterine bleeding in premenopausal women. Acta Obstet Gynecol Scand. 2003 Jun;82(6):493-504. doi: 10.1034/j.1600-0412.2003.00191.x.
Related trials for Fertility Risk
RecruitingObservational study
Gonadal Tissue Freezing for Fertility Preservation in Individuals at Risk for Ovarian Dysfunction, Premature Ovarian Insufficiency and Clinically Indicated Gonadectomy
Turner Syndrome, Post-menarcheal Adolescents
Active, not recruiting
Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer
Breast Neoplasm, Colorectal Neoplasm
Enrolling by invitationObservational study
The Longitudinal Evaluation of Ovarian Aging and Cardiovascular Risk
Infertility, Cardiovascular Risk Factor
RecruitingObservational study
AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE)
Fertility Preservation, Lymphoma
RecruitingObservational study
Towards Optimal Fertility, Fathering and Fatherhood studY
Reproductive Issues, Fertility Issues
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Subsidy for fertility consult and Invitation to purchase fertility consult in people with Fertility Risk, run by Turtle Health, Inc. at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 12 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Image quality (time frame: 6 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05509322, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Apr 2023.